|
| Category | Funding IC | Project Number | Sub Project # | Project Title | PI Name | Org Name | State / Country | Amount |
|
Vector-Borne Diseases
|
NIAID
|
1R03AI067663-01
|
|
THE POLYMORPHISM AND BIOLOGY OF LEISHMANIA BRAZILIENSIS INFECTION
|
SCHRIEFER, ALBERT
|
FEDERAL UNIVERSITY OF BAHIA
|
BRAZIL
|
$54,000
|
|
Vector-Borne Diseases
|
NIAID
|
1R03AI066253-01A1
|
|
DOUBLE NEGATIVE, CD4-CD8- T CELLS IN HUMAN LEISHMANIASIS
|
GOLLOB, KENNETH
|
UNIVERSIDADE FEDERAL DE MINAS GERAIS
|
BRAZIL
|
$54,000
|
|
Vector-Borne Diseases
|
NIAID
|
1R03AI071057-01
|
|
Spatial clustering pre and post-treatment for schistosomiasis and geohelminths
|
GAZZINELLI, ANDREA
|
UNIVERSIDADE FEDERAL DE MINAS GERAIS
|
BRAZIL
|
$75,600
|
|
Vector-Borne Diseases
|
NIGMS
|
5R01GM063879-06
|
|
Expression of Human Therapeutic Proteins in Transgenic Tobacco Chloroplasts
|
DANIELL, HENRY
|
UNIVERSITY OF CENTRAL FLORIDA
|
FL
|
$281,384
|
|
Vector-Borne Diseases
|
NIAID
|
5U01AI066327-04
|
|
Rationally designed Rift Valley Fever Virus Vaccine
|
FLICK, RAMON
|
BIOPROTECTION SYSTEMS CORPORATION
|
IA
|
$462,742
|
|
Vector-Borne Diseases
|
NIAID
|
4R37AI034867-15
|
|
Lyosome Mediated Cell Invasion by Trypanosoma Cruzi
|
ANDREWS, NORMA
|
YALE UNIVERSITY
|
CT
|
$482,934
|
|
Vector-Borne Diseases
|
NIAID
|
2P50AI030639-16
|
0013
|
The role of Leishmania braziliensis strain polymorphism on disease outcome and ..
|
SCHRIEFER, ALBERT
|
FEDERAL UNIVERSITY OF BAHIA
|
BRAZIL
|
$195,364
|
|
Vector-Borne Diseases
|
NIAID
|
2P50AI030639-16
|
0014
|
Protective and Pathogenic Immune Responses in Tegumentary Leishmania
|
CARVALHO, EDGAR
|
FEDERAL UNIVERSITY OF BAHIA
|
BRAZIL
|
$197,657
|
|
Vector-Borne Diseases
|
NIAID
|
2P50AI030639-16
|
0015
|
Genetic Determinants of Leishmaniasis
|
JERONIMO, SELMA
|
FEDERAL UNIVERSITY OF BAHIA
|
BRAZIL
|
$188,710
|
|
Vector-Borne Diseases
|
FIC
|
1D43TW007391-01A2
|
|
Tsetse Transmitted African Trypanosomiasis
|
AKSOY, SERAP
|
YALE UNIVERSITY
|
CT
|
$141,717
|
|
Vector-Borne Diseases
|
FIC
|
1R03TW007757-01A1
|
|
Molecular determinants of P. falciparum resistance to ACTs in Nigeria.
|
HAPPI, CHRISTIAN
|
UNIVERSITY OF IBADAN
|
NIGERI
|
$27,918
|
|
Vector-Borne Diseases
|
NIGMS
|
5R01GM035072-23
|
|
Gene Functions and Molecular Genetics of RNA Viruses
|
AHLQUIST, PAUL
|
UNIVERSITY OF WISCONSIN MADISON
|
WI
|
$408,508
|
|
Vector-Borne Diseases
|
NIAID
|
1R01AI068932-01A2
|
|
Evolutionary genetics of tsetse and its symbionts
|
AKSOY, SERAP
|
YALE UNIVERSITY
|
CT
|
$782,008
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI045086-11
|
|
CYTOADHERENCE IN MATERNAL MALARIA
|
GOWDA, CHANNE
|
PENNSYLVANIA STATE UNIV HERSHEY MED CTR
|
PA
|
$271,442
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI061580-03
|
|
Regulation of RNA editing in Trypansoma brucei
|
READ, LAURIE
|
STATE UNIVERSITY OF NEW YORK AT BUFFALO
|
NY
|
$294,315
|
|
Vector-Borne Diseases
|
NIGMS
|
5R01GM052216-12
|
|
Arsenate resistance in prokaryotes and eukaryotes
|
ROSEN, BARRY
|
WAYNE STATE UNIVERSITY
|
MI
|
$227,147
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI063523-04
|
|
Biosynthesis and Function of Base J
|
SABATINI, ROBERT
|
UNIVERSITY OF GEORGIA (UGA)
|
GA
|
$316,128
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI042792-09
|
|
Tick-Mammal Interface of Human Granulocytic Anaplasmosis
|
MUNDERLOH, ULRIKE
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
MN
|
$513,217
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI053835-05
|
|
Regulation of mRNA Turnover in Trypanosomes
|
BELLOFATTO, VIVIAN
|
UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL
|
NJ
|
$253,121
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI058613-40
|
|
STRUCTURE AND SYNTHESIS OF DNA
|
ENGLUND, PAUL
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$740,636
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI064831-03
|
|
Malaria: Immunity and Diversity in Low Transmission
|
BRANCH, ORALEE
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$389,480
|
|
Vector-Borne Diseases
|
NIAID
|
1R01AI075459-01
|
|
Signaling in Plasmodium falciparum: Role of PfPLC and PfPKB
|
SHARMA, PUSHKAR
|
NATIONAL INSTITUTE OF IMMUNOLOGY
|
INDIA
|
$56,160
|
|
Vector-Borne Diseases
|
NIAID
|
1R01AI075416-01
|
|
Population structure and transmission dynamics of Plasmodium vivax
|
FERREIRA, MARCELO
|
UNIVERSITY OF SAO PAULO
|
BRAZIL
|
$79,200
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI034432-14
|
|
Polyamine and glutathione metabolism in trypanosomes.
|
PHILLIPS, MARGARET
|
UNIVERSITY OF TEXAS SW MED CTR/DALLAS
|
TX
|
$326,489
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI054476-05
|
|
TYPE IV SECRETION & SIGNAL TRANSDUCTION IN EHRLICHIOSIS
|
RIKIHISA, YASUKO
|
OHIO STATE UNIVERSITY
|
OH
|
$347,649
|
|
Vector-Borne Diseases
|
NIDCD
|
5R01DC008600-02
|
|
Molecular Biology of the Odorant Receptors
|
VOSSHALL, LESLIE
|
ROCKEFELLER UNIVERSITY
|
NY
|
$319,011
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI033108-15
|
|
Endocrinology of Mosquito Reproduction
|
BROWN, MARK
|
UNIVERSITY OF GEORGIA (UGA)
|
GA
|
$270,756
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI064842-04
|
|
A new target for malaria drug development
|
LEVIN, LONNY
|
WEILL MEDICAL COLLEGE OF CORNELL UNIV
|
NY
|
$312,535
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI044005-10
|
|
Antigenic variation in rickettsial transmission
|
PALMER, GUY
|
WASHINGTON STATE UNIVERSITY
|
WA
|
$273,096
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI044238-10
|
|
Species-specific regulated transposition in mosquitoes
|
JAMES, ANTHONY
|
UNIVERSITY OF CALIFORNIA IRVINE
|
CA
|
$351,413
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI054578-04
|
|
Pathogenesis of Oxidative Stress in Chagasic Myocarditis
|
GARG, NISHA
|
UNIVERSITY OF TEXAS MEDICAL BR GALVESTON
|
TX
|
$269,050
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI029646-19
|
|
MOLECULAR GENETICS OF LEISHMANIA
|
BEVERLEY, STEPHEN
|
WASHINGTON UNIVERSITY
|
MO
|
$630,243
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI064389-04
|
|
Identification of New Antigens for a Plague Vaccine
|
CHOPRA, ASHOK
|
UNIVERSITY OF TEXAS MEDICAL BR GALVESTON
|
TX
|
$351,137
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI069313-03
|
|
Bacterial cell killing by topoisomerase I mediated DNA lesion
|
TSE-DINH, YUK-CHING
|
NEW YORK MEDICAL COLLEGE
|
NY
|
$371,495
|
|
Vector-Borne Diseases
|
NIAID
|
1R13AI075924-01
|
|
2008 Spirochetes Gordon Research Conference
|
HAAKE, DAVID
|
GORDON RESEARCH CONFERENCES
|
RI
|
$15,000
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI064553-02
|
|
Malaria HATs in Transcription Regulation
|
CUI, LIWANG
|
PENNSYLVANIA STATE UNIVERSITY-UNIV PARK
|
PA
|
$365,005
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI047953-08
|
|
Molecular Analysis of the PfEMP1 Binding Activity
|
SMITH, JOSEPH
|
SEATTLE BIOMEDICAL RESEARCH INSTITUTE
|
WA
|
$421,585
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI066095-02
|
|
Characterization of Trypanosome telomere complex
|
LI, BIBO
|
CLEVELAND STATE UNIVERSITY
|
OH
|
$302,521
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI054580-05
|
|
A new family of secreted adhesive proteins in Plasmodium
|
TEMPLETON, THOMAS
|
WEILL MEDICAL COLLEGE OF CORNELL UNIV
|
NY
|
$312,535
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI052739-05
|
|
Molecular Mechanisms in Trypanosoma cruzi Cardiomyopathy in AIDS
|
TANOWITZ, HERBERT
|
YESHIVA UNIVERSITY
|
NY
|
$388,343
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI064653-04
|
|
RNA Uridylytransferases of Trypanosomes
|
APHASIZHEV, RUSLAN
|
UNIVERSITY OF CALIFORNIA IRVINE
|
CA
|
$344,902
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI046435-08
|
|
New Alphvirus Expression Systems in Mosquitoes
|
OLSON, KENNETH
|
COLORADO STATE UNIVERSITY-FORT COLLINS
|
CO
|
$233,469
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI059377-05
|
|
Multifunctional class I transcription in T. brucei
|
GUNZL, ARTHUR
|
UNIVERSITY OF CONNECTICUT SCH OF MED/DNT
|
CT
|
$303,468
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI027811-17
|
|
Studies of Differentially Expressed Leishmania Antigens
|
MCMAHON-PRATT, DIANE
|
YALE UNIVERSITY
|
CT
|
$304,164
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI064306-04
|
|
Plasmodium sporozoites and the mosquito
|
BEERNTSEN, BRENDA
|
UNIVERSITY OF MISSOURI-COLUMBIA
|
MO
|
$388,697
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI057592-05
|
|
Immune Response to P. vivax in Duffy (-) Humans
|
WANG, RUOBING
|
SEATTLE BIOMEDICAL RESEARCH INSTITUTE
|
WA
|
$425,871
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI041233-10
|
|
RECEPTORS FOR THE TRYPANOLYTIC FACTORS FROM HUMAN SERUM
|
RAPER, JAYNE
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
NY
|
$314,396
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI054711-04
|
|
New Approaches to Schistosome vaccine antigen discovery
|
KING, CHRISTOPHER
|
CASE WESTERN RESERVE UNIVERSITY
|
OH
|
$385,690
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI057885-06
|
|
Attenuated Live and Recombinant Yersinia pestis Vaccines
|
CURTISS, ROY
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
AZ
|
$594,217
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI045741-09
|
|
Hermes Element Transposition in Mosquitoes
|
ATKINSON, PETER
|
UNIVERSITY OF CALIFORNIA RIVERSIDE
|
CA
|
$419,895
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI021786-23
|
|
Regulation of the Development of Trypanosoma brucei
|
WANG, C
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$352,300
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI037601-14
|
|
Bacterium-ECM interactions during infection by the Lyme disease spirochete
|
LEONG, JOHN
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
MA
|
$386,974
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI028798-19
|
|
RNA METABOLISM IN TRYPANOSOMES
|
ULLU, ELISABETTA
|
YALE UNIVERSITY
|
CT
|
$656,297
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI050663-06
|
|
Cross-talk among mosquito and mammalian immune factors
|
LUCKHART, SHIRLEY
|
UNIVERSITY OF CALIFORNIA DAVIS
|
CA
|
$298,344
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI063508-04
|
|
Ecological Genomics of Anopheles gambiae
|
BESANSKY, NORA
|
UNIVERSITY OF NOTRE DAME
|
IN
|
$537,240
|
|
Vector-Borne Diseases
|
NIAID
|
5R03AI064849-02
|
|
Vesicle targeting in Plasmodium falciparum
|
RAYNER, JULIAN
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$71,123
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI017252-19
|
|
Scabies: Biology, Culture, Host Specificity and Antigens
|
ARLIAN, LARRY
|
WRIGHT STATE UNIVERSITY
|
OH
|
$341,728
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI059492-04
|
|
Reverse genetics of mosquito systemic immunity
|
RAIKHEL, ALEXANDER
|
UNIVERSITY OF CALIFORNIA RIVERSIDE
|
CA
|
$463,182
|
|
Vector-Borne Diseases
|
NIAID
|
7R01AI072773-02
|
|
Transduction of Schistosoma mansoni by pseudotyped retrovirus
|
BRINDLEY, PAUL
|
GEORGE WASHINGTON UNIVERSITY
|
DC
|
$448,408
|
|
Vector-Borne Diseases
|
NIGMS
|
5R01GM057454-10
|
|
Molecular Mechanisms of Alphavirus Entry and Exit
|
KIELIAN, MARGARET
|
YESHIVA UNIVERSITY
|
NY
|
$365,200
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI046541-08
|
|
Regulation of Energy Metabolism in Insects
|
MIESFELD, ROGER
|
UNIVERSITY OF ARIZONA
|
AZ
|
$323,629
|
|
Vector-Borne Diseases
|
NIAID
|
5R21AI072170-02
|
|
Roles of host RNA binding proteins in virus replication
|
NAGY, PETER
|
UNIVERSITY OF KENTUCKY
|
KY
|
$200,124
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI065760-03
|
|
Immune Responses to Biodefense Vaccines Early in Life
|
PASETTI, MARCELA
|
UNIVERSITY OF MARYLAND BALTIMORE
|
MD
|
$353,635
|
|
Vector-Borne Diseases
|
NIGMS
|
5R01GM070559-04
|
|
Molecular Analysis of Juvenile Hormone Action
|
PALLI, SUBBA
|
UNIVERSITY OF KENTUCKY
|
KY
|
$193,429
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI059118-04
|
|
Generation of Genetically Attenuated Rickettsiae
|
AZAD, ABDU
|
UNIVERSITY OF MARYLAND BALTIMORE
|
MD
|
$414,654
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI045999-08
|
|
Molecular Targets of Blocking Malaria Transmission
|
VINETZ, JOSEPH
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$365,525
|
|
Vector-Borne Diseases
|
FIC
|
1R03TW007446-01A1
|
|
Invasive Aedes Mosquitoes and Dengue in Brazil
|
LOUNIBOS, LEON
|
UNIVERSITY OF FLORIDA
|
FL
|
$31,254
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI063530-04
|
|
Mosquito injection of Plasmodium sporozoites into skin
|
VANDERBERG, JEROME
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
NY
|
$392,994
|
|
Vector-Borne Diseases
|
NHLBI
|
5R01HL079397-04
|
|
Erythrocyte Raft Signaling In Malarial Infection
|
HALDAR, KASTURI
|
NORTHWESTERN UNIVERSITY
|
IL
|
$96,503
|
|
Vector-Borne Diseases
|
NINDS
|
5R01NS038932-06
|
|
Control of Alphavirus Replication in the Nervous System
|
GRIFFIN, DIANE
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$358,750
|
|
Vector-Borne Diseases
|
NEI
|
5R01EY010320-15
|
|
The Role of Wolbachia Endobacteria in River Blindness
|
PEARLMAN, ERIC
|
CASE WESTERN RESERVE UNIVERSITY
|
OH
|
$363,992
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI033106-13
|
|
CD8+ T cell and Trypanosoma cruzi infection
|
TARLETON, RICK
|
UNIVERSITY OF GEORGIA (UGA)
|
GA
|
$342,300
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI063233-04
|
|
Host factors in the alphavirus replication complex
|
MACDONALD, MARGARET
|
ROCKEFELLER UNIVERSITY
|
NY
|
$314,396
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI015035-31
|
|
Permeability of the Epidemic Typhus Rickettsia
|
WINKLER, HERBERT
|
UNIVERSITY OF SOUTH ALABAMA
|
AL
|
$558,107
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI062735-04
|
|
Tick polarized T-cell responses and Borrelia infection
|
WIKEL, STEPHEN
|
UNIVERSITY OF CONNECTICUT SCH OF MED/DNT
|
CT
|
$337,184
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI031951-16
|
|
Regulation of Digestion in Blood-Sucking Insects
|
MIESFELD, ROGER
|
UNIVERSITY OF ARIZONA
|
AZ
|
$323,629
|
|
Vector-Borne Diseases
|
NIGMS
|
1SC2AI080867-01
|
|
Engineering Transposon Mobility in Mosquitoes
|
PLEDGER, DAVID
|
TEXAS A&M UNIVERSITY-KINGSVILLE
|
TX
|
$131,260
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI031077-15
|
|
Protein Phosphorylation in Trypanosomes
|
PARSONS, MARILYN
|
SEATTLE BIOMEDICAL RESEARCH INSTITUTE
|
WA
|
$454,844
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI046706-08
|
|
Poly-N-acetyl glucosamine as a vaccine for bacterial pathogens
|
PIER, GERALD
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$447,179
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI035739-14
|
|
Secretion and Protein Targeting in African Trypanosomes
|
BANGS, JAMES
|
UNIVERSITY OF WISCONSIN MADISON
|
WI
|
$299,172
|
|
Vector-Borne Diseases
|
NIAID
|
7R01AI030464-17
|
|
Physiology of Insect Amino Acid Transport
|
BOUDKO, DMITRI
|
ROSALIND FRANKLIN UNIV OF MEDICINE & SCI
|
IL
|
$286,491
|
|
Vector-Borne Diseases
|
NIGMS
|
5R01GM071382-04
|
|
Transport of Folates and Their Precursors in Plants
|
HANSON, ANDREW
|
UNIVERSITY OF FLORIDA
|
FL
|
$137,961
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI051531-05
|
|
TRACK Regulates Cytokinesis in Trypanosoma brucei
|
RUBEN, LAWRENCE
|
SOUTHERN METHODIST UNIVERSITY
|
TX
|
$301,995
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI064200-04
|
|
Heterocycle Binding and Biology in the DNA Minor Groove
|
WILSON, W DAVID
|
GEORGIA STATE UNIVERSITY
|
GA
|
$304,514
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI059373-04
|
|
Outer membrane lipoproteins of Borrelia burgdorferi
|
AKINS, DARRIN
|
UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR
|
OK
|
$272,538
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI064913-04
|
|
Computational tools for T- and B-cell epitope prediction
|
BRAUN, WERNER
|
UNIVERSITY OF TEXAS MEDICAL BR GALVESTON
|
TX
|
$280,910
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI046018-08
|
|
Genetic Studies of African Anopheles Vectors of Malaria
|
POWELL, JEFFREY
|
YALE UNIVERSITY
|
CT
|
$339,232
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI041761-10
|
|
Macromolecular Transport in Asexual Malaria Parasites
|
TARASCHI, THEODORE
|
THOMAS JEFFERSON UNIVERSITY
|
PA
|
$289,421
|
|
Vector-Borne Diseases
|
FIC
|
5R01TW006612-05
|
|
Mast cell toll-like receptors and parasitic pathogens
|
ANDRADE, MARCUS
|
UNIVERSIDADE FEDERAL DE MINAS GERAIS
|
BRAZIL
|
$51,202
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI061624-04
|
|
NOS2 and arginase in visceral leishmaniasis
|
MELBY, PETER
|
UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT
|
TX
|
$289,514
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI056148-04
|
|
The Role of Host B Lymphocytes in Yersinia Pathogenesis
|
TAPPING, RICHARD
|
UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN
|
IL
|
$310,093
|
|
Vector-Borne Diseases
|
NIAID
|
1R01AI076248-01
|
|
T. cruzi: pathogenesis modulation by eicosanoids
|
TANOWITZ, HERBERT
|
YESHIVA UNIVERSITY
|
NY
|
$415,000
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI056326-05
|
|
Anti-tick-borne Encephalitis Virus Miniprotein Agents
|
FOX, ROBERT
|
UNIVERSITY OF TEXAS MEDICAL BR GALVESTON
|
TX
|
$351,137
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI030010-17
|
|
Ehrilchiacidal Mechanisms In Leukocytes
|
RIKIHISA, YASUKO
|
OHIO STATE UNIVERSITY
|
OH
|
$312,886
|
|
Vector-Borne Diseases
|
NIAID
|
5F32AI068303-03
|
|
Editosome Protein-RNA Interactions in Trypanosomes
|
TARUN, SALVADOR
|
SEATTLE BIOMEDICAL RESEARCH INSTITUTE
|
WA
|
$52,048
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI048562-09
|
|
Transfection and analysis of transcription in B. malayi
|
UNNASCH, THOMAS
|
UNIVERSITY OF SOUTH FLORIDA
|
FL
|
$340,687
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI066279-04
|
|
Trypanosomatid Mitochondrial DNA Polymerases
|
KLINGBEIL, MICHELE
|
UNIVERSITY OF MASSACHUSETTS AMHERST
|
MA
|
$292,072
|
|
Vector-Borne Diseases
|
NIGMS
|
5R01GM076637-03
|
|
Variation at Malaria Resistance Genes in Africans
|
TISHKOFF, SARAH
|
UNIVERSITY OF MARYLAND COLLEGE PK CAMPUS
|
MD
|
$5,086
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI065853-03
|
|
Roles of Lipoate Pathways in Plasmodium Survival
|
PRIGGE, SEAN
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$390,546
|
|
Vector-Borne Diseases
|
NIAID
|
5U01AI056270-05
|
|
Malaria transmission and immunity in highland Kenya
|
JOHN, CHANDY
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
MN
|
$588,686
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI055576-04
|
|
Innate and adaptive immune responses to Leishmania
|
MOSSER, DAVID
|
UNIVERSITY OF MARYLAND COLLEGE PK CAMPUS
|
MD
|
$310,793
|
|
Vector-Borne Diseases
|
NIAID
|
1R01AI076342-01
|
|
Causes and consequences of ospC variation in Borrelia burgdorferi to Lyme disease
|
BRISSON, DUSTIN
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$348,299
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI046653-08
|
|
Accelerated CD8 T cell memory after DC vaccination
|
HARTY, JOHN
|
UNIVERSITY OF IOWA
|
IA
|
$400,429
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI068137-02
|
|
Plasmodium Invasion Machinery
|
BERGMAN, LAWRENCE
|
DREXEL UNIVERSITY
|
PA
|
$595,288
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI066045-02
|
|
T. cruzi molecular targets for vector paratransgenesis
|
DURVASULA, RAVI
|
UNIVERSITY OF NEW MEXICO
|
NM
|
$352,766
|
|
Vector-Borne Diseases
|
NIAID
|
5U01AI061441-04
|
|
Imino sugars for flavivirus infections of bioterror
|
BLOCK, TIMOTHY
|
DREXEL UNIVERSITY
|
PA
|
$1,676,924
|
|
Vector-Borne Diseases
|
NIGMS
|
5R01GM079536-02
|
|
The Evolution of Malerial Antifiolate Resistance
|
HARTL, DANIEL
|
HARVARD UNIVERSITY
|
MA
|
$317,300
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI061436-04
|
|
Functional genomics of molluscan schistosome development
|
YOSHINO, TIMOTHY
|
UNIVERSITY OF WISCONSIN MADISON
|
WI
|
$335,848
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI058973-05
|
|
Artemisinin-induced Dormancy & Malaria Treatment Failure
|
KYLE, DENNIS
|
UNIVERSITY OF SOUTH FLORIDA
|
FL
|
$316,680
|
|
Vector-Borne Diseases
|
NIAID
|
1R21AI076672-01
|
|
Molecular tools to monitor eradication of Schistosoma haematobium transmission
|
KING, CHARLES
|
CASE WESTERN RESERVE UNIVERSITY
|
OH
|
$213,187
|
|
Vector-Borne Diseases
|
NIAID
|
1R21AI076684-01
|
|
Function of selected vector-induced B. burgdorferi gene-products
|
PAL, UTPAL
|
UNIVERSITY OF MARYLAND COLLEGE PK CAMPUS
|
MD
|
$184,375
|
|
Vector-Borne Diseases
|
NIAID
|
5R37AI034885-15
|
|
Peroxides for Chemotherapy of Malaria and Cancer
|
POSNER, GARY
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$406,237
|
|
Vector-Borne Diseases
|
NIAID
|
1R03AI076710-01
|
|
Malaria vectors in two major endemic areas of Colombia
|
CORREA, MARGARITA
|
UNIVERSITY OF ANTIOQUIA
|
COLOMB
|
$54,000
|
|
Vector-Borne Diseases
|
NIAID
|
1K08AI076635-01
|
|
Genetic diversity in virulence genes of Plasmodium falciparum
|
KIRKMAN, LAURA
|
WEILL MEDICAL COLLEGE OF CORNELL UNIV
|
NY
|
$130,950
|
|
Vector-Borne Diseases
|
NIAID
|
1R34AI076610-01
|
|
Safety Pharmacokinetics & Efficacy of Artemether & Lumefantrine in Pregnant Women
|
MIROCHNICK, MARK
|
BOSTON MEDICAL CENTER
|
MA
|
$123,153
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI047960-08
|
|
Trypansoma cruzi-induced host cell signaling responses
|
BURLEIGH, BARBARA
|
HARVARD UNIVERSITY (SCH OF PUBLIC HLTH)
|
MA
|
$305,094
|
|
Vector-Borne Diseases
|
NIAID
|
1R21AI076849-01
|
|
Characterization of CCR5-like Molecules in Leishmania
|
SOONG, LYNN
|
UNIVERSITY OF TEXAS MEDICAL BR GALVESTON
|
TX
|
$188,750
|
|
Vector-Borne Diseases
|
NIAID
|
1R21AI076798-01
|
|
Role of chemokines in astro-neuronal activation in cerebral malaria
|
STINS, MONIQUE
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$205,000
|
|
Vector-Borne Diseases
|
NIDDK
|
1K01DK080194-01
|
|
An epithelial model for V-type H+-ATPase-driven acid-base transport
|
PIERMARINI, PETER
|
CORNELL UNIVERSITY ITHACA
|
NY
|
$105,110
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI048071-08
|
|
Mapping Drug Resistance Genes in Plasmodium Falciparum
|
ANDERSON, TIM
|
SOUTHWEST FOUNDATION FOR BIOMEDICAL RES
|
TX
|
$461,133
|
|
Vector-Borne Diseases
|
NIAID
|
5R21AI071208-02
|
|
Selfish gene and genetic control of vector-borne diseases
|
ADELMAN, ZACH
|
VIRGINIA POLYTECHNIC INST AND ST UNIV
|
VA
|
$217,892
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI045135-08
|
|
Functional analysis of flavivirus genetic resistance.
|
BRINTON, MARGO
|
GEORGIA STATE UNIVERSITY
|
GA
|
$309,698
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI068647-03
|
|
The contractile vacuole of Trypanosoma cruzi
|
DOCAMPO, ROBERTO
|
UNIVERSITY OF GEORGIA (UGA)
|
GA
|
$350,539
|
|
Vector-Borne Diseases
|
NIAID
|
1R01AI073301-01A1
|
|
Sindbis nonstructural protein nsP2: Interaction with cellular proteins
|
FROLOVA, ELENA
|
UNIVERSITY OF TEXAS MEDICAL BR GALVESTON
|
TX
|
$339,750
|
|
Vector-Borne Diseases
|
NIAID
|
1R01AI071223-01A2
|
|
Experimental Molecular Vaccines for Schistosomiasis
|
SIDDIQUI, AFZAL
|
TEXAS TECH UNIVERSITY HEALTH SCIS CENTER
|
TX
|
$327,484
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI044102-08
|
|
Anaplasma regulation of host granulocyte functions
|
DUMLER, JOHN
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$282,078
|
|
Vector-Borne Diseases
|
NIAID
|
5R21AI072102-02
|
|
Septate junctional proteins: Proteomic identification and role in diuresis
|
BEYENBACH, KLAUS
|
CORNELL UNIVERSITY ITHACA
|
NY
|
$183,509
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI069195-02
|
|
Recurrent treatment: Effect on rural and urban S. mansoni population structure
|
BLANTON, RONALD
|
CASE WESTERN RESERVE UNIVERSITY
|
OH
|
$356,103
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI024340-21
|
|
BIOLOGY OF TREMATODE-SNAIL ASSOCIATIONS
|
LOKER, ERIC
|
UNIVERSITY OF NEW MEXICO
|
NM
|
$321,486
|
|
Vector-Borne Diseases
|
NIAID
|
2R01AI026815-20A1
|
|
Mouse Model of Lyme Borreliosis
|
BARTHOLD, STEPHEN
|
UNIVERSITY OF CALIFORNIA DAVIS
|
CA
|
$380,000
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI057992-05
|
|
Role of Regulatory T cells in Leishmania major infection
|
KARP, CHRISTOPHER
|
CHILDREN'S HOSPITAL MED CTR (CINCINNATI)
|
OH
|
$277,189
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI065935-04
|
|
T. brucei Mitochondrial Proteome
|
STUART, KENNETH
|
SEATTLE BIOMEDICAL RESEARCH INSTITUTE
|
WA
|
$812,562
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI057571-04
|
|
Alphavirus Minus Strand RNA Synthesis and RNase L
|
SAWICKI, DOROTHEA
|
UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS
|
OH
|
$275,887
|
|
Vector-Borne Diseases
|
NIAID
|
1R21AI076955-01
|
|
Novel Engineering of a P. falciparum Merozoite Surface Protein 1 Malaria Vaccine
|
HUI, GEORGE
|
UNIVERSITY OF HAWAII AT MANOA
|
HI
|
$254,320
|
|
Vector-Borne Diseases
|
NIAID
|
2R01AI021729-24
|
|
MOLECULAR GENETICS OF TRYPANOSOME ANTIGENIC VARIATION
|
CROSS, GEORGE
|
ROCKEFELLER UNIVERSITY
|
NY
|
$525,168
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI043003-09
|
|
Pathogenic Mechanisms of Cutaneous Leishmaniasis
|
SOONG, LYNN
|
UNIVERSITY OF TEXAS MEDICAL BR GALVESTON
|
TX
|
$245,797
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI065960-04
|
|
Determinants of RNA virus evolution
|
NOVELLA, ISABEL
|
UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS
|
OH
|
$358,335
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI045957-08
|
|
The Physiology of Drug Resistant Malaria
|
ROEPE, PAUL
|
GEORGETOWN UNIVERSITY
|
DC
|
$216,543
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI066227-03
|
|
Modulation of schistosome development by T cell signals
|
DAVIES, STEPHEN
|
HENRY M. JACKSON FDN FOR THE ADV MIL/MED
|
MD
|
$360,779
|
|
Vector-Borne Diseases
|
NIAID
|
2R01AI042361-10
|
|
Genomics of Mosquito Resistance to Plasmodium
|
VERNICK, KENNETH
|
PASTEUR INSTITUTE
|
FR
|
$290,682
|
|
Vector-Borne Diseases
|
NIBIB
|
5R01EB006493-03
|
|
Nanocarriers for transcutaneous delivery of vaccines
|
CLEMENTS, JOHN
|
TULANE UNIVERSITY OF LOUISIANA
|
LA
|
$486,465
|
|
Vector-Borne Diseases
|
NIAID
|
5K23AI059316-05
|
|
Molecular epidemiology of drug resistant malaria
|
LAUFER, MIRIAM
|
UNIVERSITY OF MARYLAND BALTIMORE
|
MD
|
$134,730
|
|
Vector-Borne Diseases
|
NIAID
|
2R01AI032573-15A1
|
|
Schistosome egg induced Th2 responses
|
PEARCE, EDWARD
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$311,719
|
|
Vector-Borne Diseases
|
NIAID
|
1R01AI075266-01A1
|
|
TGF-beta signaling in schistosomes
|
PEARCE, EDWARD
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$393,750
|
|
Vector-Borne Diseases
|
NIAID
|
1R01AI072465-01A1
|
|
Mapping Protein Interactions between Filaria and its Wolbachia Endosymbiont
|
UNNASCH, THOMAS
|
UNIVERSITY OF SOUTH FLORIDA
|
FL
|
$408,082
|
|
Vector-Borne Diseases
|
NIAID
|
5K24AI068903-03
|
|
Patient-Oriented Research in Tropical Infectious Diseases
|
VINETZ, JOSEPH
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$167,787
|
|
Vector-Borne Diseases
|
NIAID
|
5U01AI057565-04
|
|
Hyperphenylalaninemia in cerebral malaria
|
GRANGER, DONALD
|
UNIVERSITY OF UTAH
|
UT
|
$406,429
|
|
Vector-Borne Diseases
|
NIAID
|
2R01AI056333-06
|
|
SMALL RNAS AND THEIR ROLE IN TRYPANOSOME BIOLOGY
|
ULLU, ELISABETTA
|
YALE UNIVERSITY
|
CT
|
$371,813
|
|
Vector-Borne Diseases
|
NCI
|
5R01CA115618-03
|
|
Gender Differences in Bladder Cancer Risk Factors
|
LOFFREDO, CHRISTOPHER
|
GEORGETOWN UNIVERSITY
|
DC
|
$425,728
|
|
Vector-Borne Diseases
|
NIAID
|
5R21AI067837-02
|
|
Reversed Chloroquines as Antimalarial Agents
|
PEYTON, DAVID
|
PORTLAND STATE UNIVERSITY
|
OR
|
$214,839
|
|
Vector-Borne Diseases
|
NIAID
|
2R01AI054139-05A2
|
|
Malaria Vector Biology in Brazil: Genetics and Ecology
|
CONN, JAN
|
WADSWORTH CENTER
|
NY
|
$591,284
|
|
Vector-Borne Diseases
|
NIAID
|
2R01AI031078-16
|
|
Glycosylation Mutants of Leishmania
|
BEVERLEY, STEPHEN
|
WASHINGTON UNIVERSITY
|
MO
|
$739,661
|
|
Vector-Borne Diseases
|
NIAID
|
1R01AI067641-01A2
|
|
Immune Evasion Mechanisms of Neurovirulent Alphaviruses
|
HEISE, MARK
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$287,982
|
|
Vector-Borne Diseases
|
NIAID
|
1R01AI067954-01A2
|
|
Immunologic Determinants of Schistosoma-mediated Resistance to Malaria in Humans
|
LYKE, KIRSTEN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
MD
|
$246,750
|
|
Vector-Borne Diseases
|
NCRR
|
5P40RR014279-09
|
|
Peromyscus Laboratory Models for Biomedical Research
|
FELDER, MICHAEL
|
UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA
|
SC
|
$193,752
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI057588-05
|
|
The Role of LPS and Toll-like Receptors in Plague
|
LIEN, EGIL
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
MA
|
$342,850
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI044008-10
|
|
Adherence of malaria-infected red cells
|
COWMAN, ALAN
|
WALTER AND ELIZA HALL INST MEDICAL RES
|
AUSTRA
|
$200,916
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI065784-04
|
|
Arthropod vector-based vaccines for leishmaniasis
|
TITUS, RICHARD
|
COLORADO STATE UNIVERSITY-FORT COLLINS
|
CO
|
$429,970
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI058170-04
|
|
Metalloid transporters and drug resistance in Leishmania
|
MUKHOPADHYAY, RITA
|
WAYNE STATE UNIVERSITY
|
MI
|
$201,060
|
|
Vector-Borne Diseases
|
NIGMS
|
5R37GM052382-12
|
|
Structure and Mechanism of Protein Prenyltransferases
|
BEESE, LORENA
|
DUKE UNIVERSITY
|
NC
|
$322,297
|
|
Vector-Borne Diseases
|
NIAID
|
1R01AI071121-01A2
|
|
Determinants of growth and fitness in drug resistant malaria parasites
|
FERDIG, MICHAEL
|
UNIVERSITY OF NOTRE DAME
|
IN
|
$392,646
|
|
Vector-Borne Diseases
|
NIGMS
|
2R01GM031318-45A1
|
|
ROBBINS Glycosylation and Glycosidases-Cell and Molecular Biology
|
ROBBINS, PHILLIPS
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
MA
|
$406,250
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI067698-03
|
|
Hemocyte Transcriptome and Immunity in Aedes aegypti
|
CHRISTENSEN, BRUCE
|
UNIVERSITY OF WISCONSIN MADISON
|
WI
|
$346,491
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI047798-09
|
|
Characterization of Proplasmepsin Maturase
|
GOLDBERG, DANIEL
|
WASHINGTON UNIVERSITY
|
MO
|
$175,802
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI063434-04
|
|
Virus-Mosquito mRNA Stability
|
WILUSZ, JEFFREY
|
COLORADO STATE UNIVERSITY-FORT COLLINS
|
CO
|
$337,184
|
|
Vector-Borne Diseases
|
NIAID
|
5R21AI064645-02
|
|
Arbovirus Evasion of Type I Interferon Induction
|
HEISE, MARK
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$177,589
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI056840-04
|
|
Structure and Function of the Circumsporozoite Protein
|
SINNIS, PHOTINI
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
NY
|
$456,587
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI022501-22
|
|
Lyme Disease in Western USA: Ecology and Epidemiology
|
LANE, ROBERT
|
UNIVERSITY OF CALIFORNIA BERKELEY
|
CA
|
$353,462
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI018919-22
|
|
Immunoregulation of Schistosomiasis
|
STADECKER, MIGUEL
|
TUFTS UNIVERSITY BOSTON
|
MA
|
$380,205
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI033656-15
|
|
MOLECULAR ANALYSIS OF APICAL ORGANELLES OF PLASMODIUM
|
ADAMS, JOHN
|
UNIVERSITY OF SOUTH FLORIDA
|
FL
|
$307,305
|
|
Vector-Borne Diseases
|
NIAID
|
2R01AI051486-06
|
|
Regulation of Gene Expression in Borrelia burgdorferi
|
SAMUELS, D.
|
UNIVERSITY OF MONTANA
|
MT
|
$351,675
|
|
Vector-Borne Diseases
|
NIAID
|
1R01AI071192-01A2
|
|
VEE Virus Infection on the Mosquito Vector
|
WEAVER, SCOTT
|
UNIVERSITY OF TEXAS MEDICAL BR GALVESTON
|
TX
|
$339,750
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI056242-04
|
|
IL-12 Regulation in Leishmania Infected Dendritic Cells
|
MCDOWELL, MARY
|
UNIVERSITY OF NOTRE DAME
|
IN
|
$244,169
|
|
Vector-Borne Diseases
|
NIGMS
|
2R01GM067871-05
|
|
Structural Requirements for Sterol 14alpha-demethylase
|
WATERMAN, MICHAEL
|
VANDERBILT UNIVERSITY
|
TN
|
$345,921
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI049724-08
|
|
Ecology of Encephalitis Viruses in the USA
|
UNNASCH, THOMAS
|
UNIVERSITY OF SOUTH FLORIDA
|
FL
|
$539,274
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI044254-08
|
|
Analysis of Borrelia burgdorferi Erp Proteins
|
STEVENSON, BRIAN
|
UNIVERSITY OF KENTUCKY
|
KY
|
$348,872
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI061356-05
|
|
Mechanism of tRNA Import Into Trypanosome Mitochondria
|
HAJDUK, STEPHEN
|
UNIVERSITY OF GEORGIA (UGA)
|
GA
|
$342,998
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI055652-04
|
|
Antigen Capture Assays for Rapid Detection of Y. Pestis
|
DATTWYLER, RAYMOND
|
NEW YORK MEDICAL COLLEGE
|
NY
|
$354,951
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI053825-07
|
|
Dendritic Cell Function in Schistosomiasis
|
PEARCE, EDWARD
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$371,014
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI057142-05
|
|
Trypanosome RNA Binding Proteins
|
WILLIAMS, NOREEN
|
STATE UNIVERSITY OF NEW YORK AT BUFFALO
|
NY
|
$360,965
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI054546-05
|
|
CD14 AND THE IMMUNOPATHOGENESIS OF CHRONIC LYME DISEASE
|
SELLATI, TIMOTHY
|
ALBANY MEDICAL COLLEGE
|
NY
|
$330,675
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI045540-06
|
|
Interactions between Leishmania and the Immune Response
|
WILSON, MARY
|
UNIVERSITY OF IOWA
|
IA
|
$338,445
|
|
Vector-Borne Diseases
|
FIC
|
5R01TW007305-04
|
|
Iron supplementation in HIV-infected pregnant women
|
MWAPASA, VICTOR
|
UNIVERSITY OF MALAWI
|
MALAWI
|
$25,401
|
|
Vector-Borne Diseases
|
OD
|
5R01TW007305-04
|
|
Iron supplementation in HIV-infected pregnant women
|
MWAPASA, VICTOR
|
UNIVERSITY OF MALAWI
|
MALAWI
|
$24,412
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI012710-30
|
|
Mechanisms of Nonsterilizing Immunity in Malaria
|
WEIDANZ, WILLIAM
|
UNIVERSITY OF WISCONSIN MADISON
|
WI
|
$294,118
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI045098-10
|
|
Anion Regulation in Larvae of Disease Vector Mosquitoes
|
LINSER, PAUL
|
UNIVERSITY OF FLORIDA
|
FL
|
$304,514
|
|
Vector-Borne Diseases
|
NIDCD
|
1R03DC008193-01A1
|
|
Functional Studies of Olfactory Responses in the Proboscis of Anopheles gambiae
|
KWON, HYUNG-WOOK
|
VANDERBILT UNIVERSITY
|
TN
|
$153,500
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI067869-02
|
|
YopM and protective innate defenses against plague
|
STRALEY, SUSAN
|
UNIVERSITY OF KENTUCKY
|
KY
|
$483,485
|
|
Vector-Borne Diseases
|
NIAID
|
5R21AI069038-02
|
|
Tyrosine phosphorylation during A. phagocytophilum invasion
|
IJDO, JACOB
|
UNIVERSITY OF IOWA
|
IA
|
$180,872
|
|
Vector-Borne Diseases
|
NIAID
|
1R03AI072538-01A2
|
|
Testing DNA Vaccine Against T. cruzi in Large Animal Model (Dogs)
|
GARG, NISHA
|
UNIVERSITY OF TEXAS MEDICAL BR GALVESTON
|
TX
|
$75,500
|
|
Vector-Borne Diseases
|
NICHD
|
1K01HD055415-01A1
|
|
Population-environment dynamics influencing malaria risk in the Peruvian Amazon
|
PAN, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$133,685
|
|
Vector-Borne Diseases
|
NIAID
|
1R21AI067386-01A2
|
|
Rickettsia ricketti and Rickettsia-like organisms in Maryland
|
NORRIS, DOUGLAS
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$240,880
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI059529-05
|
|
Genesis & Control of Lyme Disease by Innate Immunity
|
BOCKENSTEDT, LINDA
|
YALE UNIVERSITY
|
CT
|
$380,205
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI058893-04
|
|
Differentiation in T.cruzi:an emerging AIDS pathogen
|
HUANG, HUAN
|
YESHIVA UNIVERSITY
|
NY
|
$347,418
|
|
Vector-Borne Diseases
|
FIC
|
5R01TW007255-04
|
|
RNA Polymerase III transcription in Leishmania major
|
MARTINEZ CALVILLO, SANTIAGO
|
UNIVERSITY OF MEXICO, UNAM
|
MEXICO
|
$51,202
|
|
Vector-Borne Diseases
|
NIAID
|
7R01AI051305-06
|
|
Genetic Basis of Severe Malarial Anemia
|
PERKINS, DOUGLAS
|
UNIVERSITY OF NEW MEXICO
|
NM
|
$579,613
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI056034-05
|
|
Kinetoplastid SL RNA biogenesis
|
CAMPBELL, DAVID
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$346,675
|
|
Vector-Borne Diseases
|
NIAID
|
1R03AI074778-01A1
|
|
Molecular epidemiology of Plasmodium reichenowi
|
RAYNER, JULIAN
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$72,500
|
|
Vector-Borne Diseases
|
NIGMS
|
2R01GM065183-06
|
|
Biochemistry of lysyl-tRNA synthetases
|
IBBA, MICHAEL
|
OHIO STATE UNIVERSITY
|
OH
|
$307,500
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI068854-02
|
|
Determinants of Schistosomiasis Re-emergence
|
SPEAR, ROBERT
|
UNIVERSITY OF CALIFORNIA BERKELEY
|
CA
|
$440,238
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI064687-04
|
|
Fetal Immunity to Falciparum Malaria
|
KING, CHRISTOPHER
|
CASE WESTERN RESERVE UNIVERSITY
|
OH
|
$359,276
|
|
Vector-Borne Diseases
|
NIAID
|
1R03AI073461-01A1
|
|
Trypanosoma brucei-induced dyshematopoiesis: blocked B lymphopoiesis
|
BLACK, SAMUEL
|
UNIVERSITY OF MASSACHUSETTS AMHERST
|
MA
|
$75,089
|
|
Vector-Borne Diseases
|
NIAID
|
1R21AI073346-01A1
|
|
Novel Immunotherapy of African Trypanosomiasis
|
MANSFIELD, JOHN
|
UNIVERSITY OF WISCONSIN MADISON
|
WI
|
$220,500
|
|
Vector-Borne Diseases
|
NIAID
|
1R21AI073354-01A1
|
|
Regulation of Host-adaptation of the Lyme disease Spirochete Borrelia burgdorferi
|
LI, CHUNHAO
|
STATE UNIVERSITY OF NEW YORK AT BUFFALO
|
NY
|
$231,900
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI058279-04
|
|
Molecular regulation of diapause in Culex pipiens
|
DENLINGER, DAVID
|
OHIO STATE UNIVERSITY
|
OH
|
$208,590
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI068109-02
|
|
Prophylactic Vaccines for Schistosomiasis
|
HARN, DONALD
|
HARVARD UNIVERSITY (SCH OF PUBLIC HLTH)
|
MA
|
$404,211
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI060792-04
|
|
Designing HTA therapy for drug resistant malaria
|
WOLF, CHRISTIAN
|
GEORGETOWN UNIVERSITY
|
DC
|
$360,904
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI059229-04
|
|
Inhibitory epitopes in malaria vaccine candidates
|
FOLEY, MICHAEL
|
LA TROBE UNIVERSITY
|
AUSTRA
|
$186,033
|
|
Vector-Borne Diseases
|
NIAID
|
2R01AI039071-11A1
|
|
Tubovesicular traffic induced in red cells in plasmodia
|
HALDAR, KASTURI
|
NORTHWESTERN UNIVERSITY
|
IL
|
$1
|
|
Vector-Borne Diseases
|
NIAID
|
1R01AI070908-01A2
|
|
Vector and Host Contributions to the Regulation of E. chaffeensis Gene Expression
|
GANTA, ROMAN
|
KANSAS STATE UNIVERSITY
|
KS
|
$365,000
|
|
Vector-Borne Diseases
|
NIGMS
|
5R01GM048102-15
|
|
hobo-like elements in insects
|
O'BROCHTA, DAVID
|
UNIVERSITY OF MD BIOTECHNOLOGY INSTITUTE
|
MD
|
$354,342
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI058515-05
|
|
Plasmodium Genome Database
|
STOECKERT, CHRISTIAN
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$602,142
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI046438-09
|
|
LIVER MEMORY CD8 T CELLS IN PROTECTION TO MALARIA
|
KRZYCH, URSZULA
|
HENRY M. JACKSON FDN FOR THE ADV MIL/MED
|
MD
|
$345,027
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI061576-04
|
|
Anopheles responses to Plasmodium infected blood
|
DIMOPOULOS, GEORGE
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$381,367
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI063480-04
|
|
A gene map for Biomphalaria glabrata, a S. mansoni host
|
KNIGHT, MATTY
|
BIOMEDICAL RESEARCH INSTITUTE
|
MD
|
$567,603
|
|
Vector-Borne Diseases
|
NIAID
|
5R37AI049200-08
|
|
Tissue-specific Borrelia Gene Expression
|
FIKRIG, EROL
|
YALE UNIVERSITY
|
CT
|
$361,191
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI045545-08
|
|
Regulation of juvenile hormone titers in mosquitoes
|
NORIEGA, FERNANDO
|
FLORIDA INTERNATIONAL UNIVERSITY
|
FL
|
$343,243
|
|
Vector-Borne Diseases
|
NIDCD
|
5R01DC008834-02
|
|
Molecular basis of olfactory perception.
|
JONES, DAVID
|
UNIVERSITY OF COLORADO DENVER
|
CO
|
$289,064
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI057905-04
|
|
Studies on ZAP, a broad-spectrum alphavirus inhibitor
|
MACDONALD, MARGARET
|
ROCKEFELLER UNIVERSITY
|
NY
|
$353,697
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI058086-03
|
|
Host Spirochete Interactions in Lyme Disease
|
SKARE, JONATHAN
|
TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR
|
TX
|
$346,491
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI073660-03
|
|
Function and pharmacology of schistosome multidrug resistance proteins
|
GREENBERG, ROBERT
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$347,642
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI045774-08
|
|
Plasmodium Falciparum Metal Metabolism
|
SULLIVAN, DAVID
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$316,724
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI029478-17
|
|
Analysis of Trypanosome mRNA Synthesis by Gene Transfer
|
BELLOFATTO, VIVIAN
|
UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL
|
NJ
|
$463,458
|
|
Vector-Borne Diseases
|
NCRR
|
1S10RR024611-01
|
|
A High-Throughput Crystallization Screening System for the UCSC Macromolecular X-
|
NOLLER, HARRY
|
UNIVERSITY OF CALIFORNIA SANTA CRUZ
|
CA
|
$250,093
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI043906-10
|
|
Human immunity to MSP-1 in Western Kenya
|
KAZURA, JAMES
|
CASE WESTERN RESERVE UNIVERSITY
|
OH
|
$589,100
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI049162-08
|
|
Structure and Function of Schistosome Neuropeptide F
|
DAY, TIMOTHY
|
IOWA STATE UNIVERSITY
|
IA
|
$299,201
|
|
Vector-Borne Diseases
|
NIAID
|
5F32AI066825-03
|
|
Immune modulation by Borrelia burgdorferi
|
HEILPERN, ANDREW
|
TUFTS MEDICAL CENTER
|
MA
|
$53,992
|
|
Vector-Borne Diseases
|
NIGMS
|
5R01GM072003-05
|
|
Bayesian Models for Detecting Selection in Malaria Genes
|
PRADO, RAQUEL
|
UNIVERSITY OF CALIFORNIA SANTA CRUZ
|
CA
|
$88,582
|
|
Vector-Borne Diseases
|
FIC
|
5D43TW007375-04
|
|
Training in Malaria Research in Uganda
|
ROSENTHAL, PHILIP
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$141,717
|
|
Vector-Borne Diseases
|
FIC
|
5D43TW007390-04
|
|
Training in the biology of malaria vectors in Mali
|
LANZARO, GREGORY
|
UNIVERSITY OF CALIFORNIA DAVIS
|
CA
|
$141,717
|
|
Vector-Borne Diseases
|
FIC
|
5D43TW007127-05
|
|
TROPICAL INFECTIOUS DISEASE TRAINING GRANT
|
CARVALHO, EDGAR
|
FEDERAL UNIVERSITY OF BAHIA
|
BRAZIL
|
$133,950
|
|
Vector-Borne Diseases
|
FIC
|
5D43TW001503-09
|
|
Training in Malaria Pathogenesis and Diversity in Africa
|
WIRTH, DYANN
|
HARVARD UNIVERSITY (SCH OF PUBLIC HLTH)
|
MA
|
$141,717
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI069387-02
|
|
Modeling lymphatic filariasis transmission and eradication in Papua New Guinea
|
MICHAEL, EDWIN
|
U OF L IMPERIAL COL OF SCI/TECHNLGY/MED
|
UK
|
$132,435
|
|
Vector-Borne Diseases
|
NIAID
|
1R43AI077109-01
|
|
Isolation and Antimalarial Activity of Small Molecules from Ocimum sanctum
|
ZHU, SHUREN
|
RADIX PHARMACEUTICALS, INC.
|
MD
|
$300,000
|
|
Vector-Borne Diseases
|
NIAID
|
5R37AI024424-23
|
|
MOLECULAR BASIS OF BORRELIA PATHOGENESIS
|
BARBOUR, ALAN
|
UNIVERSITY OF CALIFORNIA IRVINE
|
CA
|
$350,963
|
|
Vector-Borne Diseases
|
FIC
|
5D43TW007129-05
|
|
Interhemispheric Research/Training in Infectious Disease
|
TANOWITZ, HERBERT
|
YESHIVA UNIVERSITY
|
NY
|
$133,950
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI053680-05
|
|
Targeting malarial dihydroorotate dehydrogenase
|
PHILLIPS, MARGARET
|
UNIVERSITY OF TEXAS SW MED CTR/DALLAS
|
TX
|
$405,500
|
|
Vector-Borne Diseases
|
FIC
|
5D43TW000924-08
|
|
Research Training on Intracellular Pathogens
|
STUART, KENNETH
|
SEATTLE BIOMEDICAL RESEARCH INSTITUTE
|
WA
|
$141,717
|
|
Vector-Borne Diseases
|
NHLBI
|
5R01HL087290-02
|
|
Nitric oxide protects against microcirculatory complications of malaria
|
CARVALHO, LEONARDO
|
LA JOLLA BIOENGINEERING INSTITUTE
|
CA
|
$426,150
|
|
Vector-Borne Diseases
|
FIC
|
5D43TW001589-08
|
|
Malaria Research Training in Mali
|
PLOWE, CHRISTOPHER
|
UNIVERSITY OF MARYLAND BALTIMORE
|
MD
|
$141,717
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI044913-10
|
|
Evo-epidemiology of Schistosoma mansoni in western Kenya
|
LOKER, ERIC
|
UNIVERSITY OF NEW MEXICO
|
NM
|
$263,935
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI029735-18
|
|
RpoS Regulation of Borrelia burgdorferi Genes in vivo
|
RADOLF, JUSTIN
|
UNIVERSITY OF CONNECTICUT SCH OF MED/DNT
|
CT
|
$528,612
|
|
Vector-Borne Diseases
|
NIAID
|
5R01AI040196-09
|
|
Trypanosoma cruzi Mucosal & Systemic Protective Immunity
|
HOFT, DANIEL
|
SAINT LOUIS UNIVERSITY
|
MO
|
$370,000
|
|
Vector-Borne Diseases
|
NIAID
|
5R21AI067281-02
|
|
Genotypic and Phenotypic Analysis of West Nile virus, Yucatan Peninsula of Mexico
|
BLITVICH, BRADLEY
|
IOWA STATE UNIVERSITY
|
IA
|
$160,195
|
|
Vector-Borne Diseases
|
NIAID
|
1R43AI077156-01
|
|
Broad Detection System for Tick-Borne Pathogens
|
ESHOO, MARK
|
IBIS BIOSCIENCES, INC.
|
CA
|
$95,502
|
|
Vector-Borne Diseases
|
NIAID
|
1R43AI074146-01A1
|
|
Small Molecule West Nile Virus Inhibitors
|
ANTHONY, KAREN
|
L2 DIAGNOSTICS, LLC
|
CT
|
$200,994
|
|
Vector-Borne Diseases
|
NIAID
|
1R43AI077262-01
|
|
Improving Production of Attenuated Malaria Sporozoite Vaccines through Genetic Mo
|
BILLINGSLEY, PETER
|
SANARIA, INC.
|
MD
|
$300,000
|
|
Vector-Borne Diseases
|
NIAID
|
1R43AI077159-01
|
|
Lyme Disease Diagnostics Using In Vivo Expressed Borrelia Burgdorferi Antigens
|
LEDIZET, MICHEL
|
L2 DIAGNOSTICS, LLC
|
CT
|
$275,834
|
|
Vector-Borne Diseases
|
NHLBI
|
2R44HL076946-02
|
|
Single Well MPCR Donor Screen to ID Blood Pathogens
|
RANKEN, RAYMOND
|
IBIS BIOSCIENCES, INC.
|
CA
|
$338,153
|
|
Vector-Borne Diseases
|
NIAID
|
1R43AI077254-01
|
|
Recombinant Adenoviral Vector with Encoded TLR3 Ligand for Protection Against VEE
|
TUCKER, SEAN
|
VAXART, INC.
|
CA
|
$219,512
|
|
